9J19
The crystal structure of COVID-19 main protease in complex with an inhibitor minocycline
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2023-09-17 |
Detector | RIGAKU HyPix-6000HE |
Wavelength(s) | 1.54184 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 67.945, 90.763, 101.307 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 23.170 - 2.700 |
R-factor | 0.25334 |
Rwork | 0.250 |
R-free | 0.31415 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 7alh |
RMSD bond length | 0.005 |
RMSD bond angle | 1.307 |
Data reduction software | CrysalisPro |
Data scaling software | Aimless |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0403) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 23.960 | 2.830 |
High resolution limit [Å] | 2.700 | 2.700 |
Rmerge | 0.185 | |
Number of reflections | 17733 | 2348 |
<I/σ(I)> | 9.7 | |
Completeness [%] | 99.6 | |
Redundancy | 10.5 | |
CC(1/2) | 0.990 | 0.927 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 293 | 24% PEG 4000, 100 mM HEPES, PH 7.5, 3% DMSO |